Trials / Completed
CompletedNCT05542160
Effectiveness of IRK-19® on Body Weight Control
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Greenyn Biotechnology Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This randomized, double-blind, placebo-controlled, and parallel clinical study aims to investigate the effectivness of a pumpkin seed extract (IRK-19®) on weight management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Pumpkin seed extract (IRK-19) | Placebo: Dietary fiber powder, two capsules/day (600 mg/day), continued use for 3 months Treatment: Pumpkin seed extract powder, two capsules/day (600 mg/day), continued use for 3 months |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2024-02-29
- Completion
- 2024-06-30
- First posted
- 2022-09-15
- Last updated
- 2024-08-09
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05542160. Inclusion in this directory is not an endorsement.